Pier Pasquale Leone
Latest contributions
Beyond the intervention: outcomes of CTO PCI
22 May 2025 – From EuroPCR 2025
Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.

Innovation to address unmet clinical needs in transcatheter valve therapies
22 May 2025 – From EuroPCR 2025
Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.

Hotline TAVI 2: outcomes with new and established devices
21 May 2025 – From EuroPCR 2025
Review outcomes of new and established TAVI devices through pooled analyses and multicenter studies. Topics include comparisons of balloon-expandable valves, intra- versus supra-annular self-expanding valves, and insights from the ACURATE IDE and ACURATE prime studies.

Calcified lesions: one big challenge; several good options
17 May 2024 – From EuroPCR 2024
This session delves into the management of calcified coronary lesions, presenting various techniques and tools to address this common challenge. It covers topics such as the use of drug-coated balloons, rotational atherectomy, intravascular lithotripsy, and high-pressure non-compliant balloons. The session also includes a meta-analysis on the...

Left main coronary interventions from basics to stenting techniques
15 May 2024 – From EuroPCR 2024

PCR's Got Talent - Round 1 - Session 1
16 May 2023 – From EuroPCR 2023
Have you attended this session and wish a memory boost? Look at the slides presented by the speakers and review what is important to remember.

Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...

Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...

Rapid-fire abstracts: session 1
27 Nov 2022 – From PCR London Valves 2022
Watch this PCR LV 2022 session to get clinical outcomes after TAVR in obese and non-obese patients with small aortic annuli, to find out how non-calcific aortic valve tissue quantified from coronary CT angiography can predict one-year mortality post-TAVI, and even more!

TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.

PCR's Got Talent - Round 2 - Session 2
18 May 2022 – From EuroPCR 2022
View this session to discover the abstracts submitted during the second round of the second session of EuroPCR 2022 PCR's Got Talent, a unique abstract competition for young practitioners.

PCR's Got Talent - Round 1 - Session 2
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of cases presented during the round 1 of PCR's Got Talent at EuroPCR 2022: tricuspid regurgitation and right ventricular-pulmonary artery coupling, TAVI vs. medical therapy in patients with borderline severe classical LFLG AS, the LIRA sizing method of TAVR...
